Clinical trial

The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis

NCT00330135 · Daiichi Sankyo, Industry · Terminated

Key facts

NCT number NCT00330135
Title The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis
Official title Multicentre, Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Investigate the Efficacy of Sodium Hyaluronate in Patients With Symptomatic Hip Osteoarthritis
Lead sponsor Daiichi Sankyo, Industry
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Symptomatic Hip Osteoarthritis
Intervention type Drug
Interventions Sodium hyaluronate, placebo injection
Enrollment 85
Start date Jan 1, 2005
Primary completion Mar 1, 2007
Completion Mar 1, 2007
First posted May 25, 2006
Last update posted Jan 9, 2008
Countries France

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies